METHOD AND INTERMEDIATES FOR THE SYNTHESIS OF KORUPENSAMINES
    4.
    发明申请
    METHOD AND INTERMEDIATES FOR THE SYNTHESIS OF KORUPENSAMINES 审中-公开
    用于合成KORUPENSAMINES的方法和中间体

    公开(公告)号:WO1996015111A1

    公开(公告)日:1996-05-23

    申请号:PCT/US1995014896

    申请日:1995-11-13

    Abstract: A method of preparing a korupensamine or an analog thereof comprising: (a) reacting a compound of formula (III), wherein each of R and R is CH3 or H, X is I, Y is (C1-C4)alkyl, benzyl or CHO, and each of R and R is (C1-C4)alkyl, benzyl, (C2-C5)acyl or an acid-labile hydroxy protecting group; with a compound of formula (IV), wherein R is benzyl, (C2-C5)acyl or an acid-labile hydroxy protecting group, R is B(OH)2, and R is (C1-C4)alkyl; in the presence of a Pd(0) catalyst and an inorganic base in an organic solvent, to yield a compound of formula (V), wherein Y, R , R , R , R , R and R are as defined above for compounds of formula (III) and (IV). Additionally the intermediates of formula (III), wherein X is Br, Cl or I, Y is H, (C1-C4)alkyl, benzyl, or CHO, each of R and R 3 is a protecting group selected from the group consisting of (C1-C4)alkyl, benzyl, (C2-C5)acyl and an acid-labile hydroxy protecting group; and R is H or (C2-C5)acyl; or wherein X is Br, Cl or I, Y is H, (C1-C4)alkyl, benzyl, or CHO, each of R and R is H or CH5, R is H or (C2-C5)acyl and R is a protecting group selected from the group consisting of (C1-C4)alkyl, benzyl, (C2-C5)acyl and an acid-labile hydroxy protecting group; and the intermediates of formula (IV), wherein R is Cl, Br, I, B(OH)2, an anhydride or ester of B(OH)2, or OSO2R , wherein R is (C1-C4)perfluoroalkyl, and each of R and R is H, (C1-C4)alkyl, benzyl, (C2-C5)acyl or an acid-labile hydroxy protecting group.

    Abstract translation: 一种制备高甘露聚糖或其类似物的方法,包括:(a)使式(III)化合物与其中R 1和R 2各自为CH 3或H的化合物反应,X为I,Y为(C1- C4)烷基,苄基或CHO,R 3和R 4各自为(C 1 -C 4)烷基,苄基,(C 2 -C 5)酰基或酸不稳定羟基保护基; 与式(IV)化合物反应,其中R 5为苄基,(C 2 -C 5)酰基或酸不稳定羟基保护基,R 6为B(OH)2,R 7为( C1-C4)烷基; 在Pd(0)催化剂和无机碱存在下,在有机溶剂中,得到式(Ⅴ)化合物,其中Y,R 1,R 2,R 3,R 4 >,R 5和R 7如上文对式(III)和(IV)化合物所定义。 另外,式(III)的中间体,其中X是Br,Cl或I,Y是H,(C1-C4)烷基,苄基或CHO,R 1和R 2各自为H或CH 3 <,R 3>是选自(C 1 -C 4)烷基,苄基,(C 2 -C 5)酰基和酸不稳定羟基保护基的保护基; 和R 4是H或(C 2 -C 5)酰基; 或其中X是Br,Cl或I,Y是H,(C1-C4)烷基,苄基或CHO,R 1和R 2各自是H或CH 5,R 3是H或( C 2 -C 5)酰基和R 4是选自(C 1 -C 4)烷基,苄基,(C 2 -C 5)酰基和酸不稳定羟基保护基的保护基; 和式(Ⅳ)的中间体,其中R 6是Cl,Br,I,B(OH)2,B(OH)2的酸酐或酯或OSO 2 R 9,其中R 9是 (C 1 -C 4)全氟烷基,R 5和R 7各自为H,(C 1 -C 4)烷基,苄基,(C 2 -C 5)酰基或酸不稳定羟基保护基。

Patent Agency Ranking